Johnson & Johnson Pricing Spineometer: 4 of 5 Vertebrae

Johnson & Johnson, a global pharmaceutical and medical technology company, had a positive Q1 2024. Revenue rose 2.3% to $21.4 billion and earnings before interest and taxes rose 3.9% to $6.1 billion over the same period last year. A review of Johnson & Johnson’s April 16th earnings call and associated financial reports provided insight regarding…